An immunohistochemical evaluation of c-erbb-2 expression in human breast carcinoma

British Journal of Cancer

Volumn 58, Issue 4, 1988, Pages 448-452

  Barnes, D M ^a   Lammie, G A ^b   Millis, R R ^a   Gullick, W L ^c   Allen, D S ^a   Altman, D G ^a  

^a IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^b GUY S HOSPITAL   (United Kingdom)

^c HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BREAST CARCINOMA; FEMALE; GENE AMPLIFICATION; GENE EXPRESSION; HISTOCHEMISTRY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; ONCOGENE C ERB; ONCOGENE NEU; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CARCINOMA, INTRADUCTAL, NONINFILTRATING; CELL MEMBRANE; FEMALE; GENE AMPLIFICATION; HUMAN; MIDDLE AGE; PROGNOSIS; PROTO-ONCOGENES; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE;

EID: 0023692302     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.1988.238     Document Type: Article

References (24)

1. AKIYAMA, T., SUDO, C., OGAWARA, H., TOYOSHIMA, K. & YAMAMOTO, T. (1986). The product of the human c-erbB-2 gene: A 185-kilodalton glycoprotein with tyrosine kinase activity. Science, 232, 1644.
2. BARGMANN, C.I., HUNG, M. & WEINBERG, R.A. (1985). The neu oncogene encodes an epidermal growth factor receptor-related protein. Nature, 319, 226.
3. BISHOP, J.M. (1987). The molecular genetics of cancer. Science, 235, 305.
4. BLOOM, H.J.C. & RICHARDSON, W.W. (1957). Histological grading and prognosis in breast cancer. Br. J. Cancer, 11, 359.
5. CHAN, V.T.W. & MCGEE, J.O.D. (1987). Cellular oncogenes in neoplasia. J. Clin. Pathol., 40, 1055.
6. DI FIORE, P., PIERCE, J.H., KRAUS, M.H., SEGATTO, O., KING, C.R. & AARONSON, S.A. (1987). c-erbB-2 is a potent oncogene when overexpressed in NlH/3T3 cells. Science, 237, 178.
7. DIXON, W.J. (1985). BMDP statistical software. Berkeley: University of California Press.
8. ESCOT C., THEILLET, C. & LIDEREAU, R. (1986). Genetic alteration of the c-myc proto-oncogene (myc) in human primary breast carcinomas. Proc. Natl Acad. Sci. USA, 83, 4834.
9. GULLICK, W.J., BERGER, M.S., BENNETT, P.L.P., ROTHBARD, J.B. & WATERFIELD, M.D. (1987). Expression of c-erbB-2 protein in normal and transformed cells. Int. J. Cancer, 40, 246.
10. GUSTERSON, B.A., GULLICK, W.J., VENTER, D.J. & 5 others (1988). Immunohistochemical localisation of c-erbB-2 in human breast cancer. Cell. Molec. Probes, 2, 383.
11. HAYWARD, J.L., MEAKIN, J.W. & STEWART, H.J. (1978). Assessment of response and recurrence in breast cancer. Semin. Oncol., 5, 445.
12. KING, R.J.B., HAYWARD, J.L., KUMAOKA, S. & YAMAMOTO, H. (1977). Comparison of soluble oestrogen and progestin receptor content on primary breast tumours from Japan and Britain. Eur. J. Cancer, 13, 967.
13. PETO, R., PIKE, M.C., ARMITAGE, P. & 7 others (1977). Design and analysis of randomised clinical trials requiring prolonged observation of each patient. II. Analysis and examples. Br. J. Cancer, 35, 1.
14. RUBENS, R.D., HAYWARD, J.L., KNIGHT, R.K. & 9 others (1983). Controlled trial of adjuvant chemotherapy with melphalan for breast cancer. Lancet, i, 839.
15. SEEGER, R.C., BRODEUR, G.M., SATHER, H. & 4 others (1985). Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas. N. Engl. J. Med., 313, 1111.
16. SCHECHTER, A.L., STERN, D.F., VAIDYANATHAN, L. & 4 others (1984). The neu oncogene: an erb-B-related gene encoding a 185, 000-Mr tumour antigen. Nature, 312, 513.
17. SEMBA, K., KAMATA, N., TOYOSHIMA, K. & YAMAMOTO, T. (1985). A v-erbB-related proto-oncogene, c-erbB-2, is distinct from the c-erbB-1/EGF-receptor gene and is amplified in human salivary gland adenocarcinoma. Proc. Natl Acad. Sci. USA, 82, 6497.
18. SLAMON, D.J., CLARK, G.M., WONG, S.G., LEVIN, W.J., ULLRICH, A. & MCGUIRE, W.J. (1987). Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science, 235, 177.
19. VAN DE VIJVER, M., VAN DE BERSSELAAR, R., DEVILEE, P., CORNELISSE, C., PETERSE, J. & NUSSE, R. (1987). Amplification of the neu (c-erbB-2) oncogene in human mammary tumours is relatively frequent and is often accompanied by amplification of the linked c-erbA oncogene. Mol. Cell. Biol., 7, 2019.
20. VAN DE VIJVER, M., MOOI, W.J., WISMAN, P., PETERSE, J.L. & NUSSE, R. (1988). Immunohistochemical detection of the neu protein in tissue sections of human breast tumours with amplified neu DNA. Oncogene, 2, 175.
21. VENTER, D.J., KUMAR, S., TUZI, N.L. & GULLICK, W.J. (1987). Overexpression of the c-erbB-2 oncoprotein in human breast carcinomas: immunohistochemical assessment correlates with gene amplification. Lancet, ii, 69.
22. YAMAMOTO, T., IKAWA, S., AKIYAMA, T. & 5 others (1986). Similarity of protein encoded by human c-erbB-2 gene to epidermal growth factor receptor. Nature, 319, 230.
23. YOKOTA, J., TOYOSHIMA, K., SUGIMURA, T. & 4 others (1986). Amplification of c-erbB-2 oncogene in human adenocarcinomas in vivo. Lancet, 1, 765.
24. ZHOU, D., BATTIFORA, H., YOKOTA, J., YAMAMOTO, T. & CLINE, M.J. (1987). Association of multiple copies of the c-erbB-2 oncogene with spread of breast cancer. Cancer Res., 47, 6123.